SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Prevalence of pathogenic variants and digenic disease in patients diagnosed with normosmic hypogonadotropic hypogonadism/Kallmann Syndrome

Poch, A; Dougherty, MP; Roman, RA; Chorich, L; Hawkins, Z; Kim, S-H; Kim, H-G; Layman, LC (2024) Prevalence of pathogenic variants and digenic disease in patients diagnosed with normosmic hypogonadotropic hypogonadism/Kallmann Syndrome. Molecular and Cellular Endocrinology, 589. p. 112224. ISSN 0303-7207 https://doi.org/10.1016/j.mce.2024.112224
SGUL Authors: Kim, Soo-Hyun

[img] Microsoft Word (.docx) Accepted Version
Restricted to Repository staff only until 7 April 2025.
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (147kB)

Abstract

Background Hypogonadotropic hypogonadism (HH) is due to impaired gonadotropin releasing hormone (GnRH) action resulting in absent puberty and infertility. At least 44 genes have been identified to possess genetic variants in 40–50% of nHH/KS, and 2–20% have presumed digenic disease, but not all variants have been characterized in vitro. Hypothesis The prevalence of pathogenic (P)/likely pathogenic (LP) variants in monogenic and digenic nHH/KS is lower than reported. Design Cross-sectional study. Setting University Research Laboratory. Subjects 158 patients with nHH/KS. Methods Exome sequencing (ES) was performed and variants were filtered for 44 known genes using Varsome and confirmed by Sanger Sequencing. Main outcome measures P/LP variants in nHH/KS genes. Results ES resulted in >370,000 variants, from which variants in 44 genes were filtered. Thirty-one confirmed P/LP variants in 10 genes (ANOS1, CHD7, DUSP6, FGFR1, HS6ST1, KISS1, PROKR2, SEMA3A, SEMA3E, TACR3), sufficient to cause disease, were identified in 30/158 (19%) patients. Only 2/158 (1.2%) patients had digenic variant combinations: a male with hemizygous ANOS1 and heterozygous TACR3 variants and a male with heterozygous SEMA3A and SEMA3E variants. Two patients (1.2%) had compound heterozygous GNRHR (autosomal recessive) variants—one P and one variant of uncertain significance (VUS). Five patients (3.2%) had heterozygous P/LP variants in either GNRHR or TACR3 (both autosomal recessive), but no second variant. Conclusion Our prevalence of P/LP variants in nHH/KS was 19%, and digenicity was observed in 1.2%. These findings are less than those previously reported, and probably represent a more accurate estimation since VUS are not included.

Item Type: Article
Additional Information: © 2024. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
Keywords: 06 Biological Sciences, 07 Agricultural and Veterinary Sciences, 11 Medical and Health Sciences, Endocrinology & Metabolism
Journal or Publication Title: Molecular and Cellular Endocrinology
ISSN: 0303-7207
Language: en
Dates:
DateEvent
1 August 2024Published
7 April 2024Published Online
29 March 2024Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
Projects:
Project IDFunderFunder ID
HD33004National Institute of Child Health and Human Developmenthttp://dx.doi.org/10.13039/100000071
URI: https://openaccess.sgul.ac.uk/id/eprint/116417
Publisher's version: https://doi.org/10.1016/j.mce.2024.112224

Actions (login required)

Edit Item Edit Item